|
|
New No.3, Appaiar Lane, Second Floor,
Royapuram, Chennai - 600 013, Tamilnadu, India
Email - , Phone - +9144 25984175, Mobile - +91 94441 62346
|
|
|
FAQ
> Glossary of Terms > I Series > Impurity
|
| |
Pharmaceutical & Cleanroom Glossary of Terms
A Series , B
Series , C Series , D
Series , E Series , F
Series , G Series , H
Series , I Series , K Series
, L Series , M
Series , N Series , O
Series , P Series , Q
Series , R Series , S
Series , T Series , U
Series , V Series , W
Series , X
Series , Y Series , Z
Series
IBC(Intermediate
Bulk Container), IDLH(Immediately
Dangerous to Life and Health), Immune
Response, Immuno
Electrophoresis, Immunity,
Immunogen, Immunoglobulin-Ig,
Immunoglobulin
A - IgA, Immunoglobulin(IgA,
IgD, IgE, IgG, IgM), Immunology,
Immunoproteins,
Imprinting, Impurity,
Impurity Profile,
Inactive Ingredient,
Inactivation, Incidential
Release, Inclusion
Body, Inclusions,
IND(Investigational
New Drug) Application, Indirect
Impact System, Inert,
Infarct, Infected,
Infectious, Infectious
Agent, Infiltration,
Informatics, Infusion,
Injection, In-line,
In-process Control,
Innocuous, Inoculum
Learn About Deadly
Cancer Mesothelioma due to Asbestos Exposure, it can affect
any one in the world
Impurity
Any component present in the intermediate or API (Active Pharmaceutical
Ingredient) that is not the desired entity. It may be either process
or product related
|
|
| |
|
|
|